Wendye Rae Robbins, MD
Pain Medicine · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Robbins’s office at (650) 723-6238 to ask if they take your plan before you enroll.
California Medical Board record
Licence G80044 · Current
Licensed to practise in California · since 1994 · expires 2027-12-31 · Medical College of Pennsylvania.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Anesthesiology - Anesthesiology
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 11 Part D prescriptions in 2023. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 11 | None | 0% (0) | None | $513 |
| 2016 | 219 | 51 | 16% (36) | 16% | $30,791 |
| 2015 | 257 | 63 | 28% (73) | 20% | $37,761 |
| 2014 | 272 | 50 | 22% (60) | 24% | $42,744 |
| 2013 | 165 | 38 | 33% (54) | 38% | $31,188 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 6 drugs
| Lyrica | 24 | $14,721 | $613 |
| Lidocaine | 15 | $3,645 | $243 |
| Duloxetine | 51 | $2,921 | $57 |
| Gabapentin | 27 | $805 | $30 |
| Topiramate | 14 | $122 | $9 |
| Tramadol | 18 | $96 | $5 |
2015: 5 drugs
| Lyrica | 27 | $14,280 | $529 |
| Duloxetine | 56 | $4,978 | $89 |
| Gabapentin | 36 | $768 | $21 |
| Tramadol | 27 | $254 | $9 |
| Temazepam | 12 | $64 | $5 |
2014: 7 drugs
| Lyrica | 27 | $11,810 | $437 |
| Duloxetine | 42 | $10,674 | $254 |
| Lidoderm | 11 | $5,750 | $523 |
| Oxycontin | 16 | $4,498 | $281 |
| Gabapentin | 44 | $1,016 | $23 |
| Tramadol | 16 | $783 | $49 |
| Baclofen | 11 | $197 | $18 |
2013: 4 drugs
| Cymbalta | 23 | $7,896 | $343 |
| Lyrica | 15 | $5,920 | $395 |
| Oxycontin | 16 | $5,831 | $364 |
| Gabapentin | 15 | $724 | $48 |
Money from drug and device companies
$383 in 2025
| 2025 | 1 | 4 | None | $383 |
| 2020 | 1 | 1 | None | $225 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Lorbrena | $383 | 4 payments
|
See all 4 published payments
| Pfizer | Meals · 2025-10-18 | Lorbrena | $25 |
| Pfizer | Meals · 2025-01-15 | None | $101 |
| Pfizer | Meals · 2025-01-14 | None | $128 |
| Pfizer | Meals · 2025-01-13 | None | $129 |
See earlier years (2020)
2020: $225
| E.R. Squibb & Sons L.L.C. | None | $225 | 1 payment
|
Professional record
- NPI
- 1639205438
- Licence
- CA G80044California G80044: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G800440
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X)
- Mailing address
- 780 Welch Rd, Ste 208e, Palo Alto, CA, 94304
- NPI first listed
- 2007-02-26
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.